Cited 20 time in
Gecko Proteins Exert Anti-Tumor Effect against Cervical Cancer Cells Via PI3-Kinase/Akt Pathway
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Jeong, Ae-Jin | - |
| dc.contributor.author | Chung, Chung-Nam | - |
| dc.contributor.author | Kim, Hye-Jin | - |
| dc.contributor.author | Bae, Kil Soo | - |
| dc.contributor.author | Choi, Song | - |
| dc.contributor.author | Jun, Woo Jin | - |
| dc.contributor.author | Shim, Sang In | - |
| dc.contributor.author | Kang, Tae-Hong | - |
| dc.contributor.author | Leem, Sun-Hee | - |
| dc.contributor.author | Chung, Jin Woong | - |
| dc.date.accessioned | 2022-12-27T01:36:55Z | - |
| dc.date.available | 2022-12-27T01:36:55Z | - |
| dc.date.issued | 2012-10 | - |
| dc.identifier.issn | 1226-4512 | - |
| dc.identifier.issn | 2093-3827 | - |
| dc.identifier.uri | https://scholarworks.gnu.ac.kr/handle/sw.gnu/21974 | - |
| dc.description.abstract | Anti-tumor activity of the proteins from Gecko (GP) on cervical cancer cells, and its signaling mechanisms were assessed by viable cell counting, propidium iodide (PI) staining, and Western blot analysis. GP induced the cell death of HeLa cells in a dose-dependent manner while it did not affect the viability of normal cells. Western blot analysis showed that GP decreased the activation of Akt, and co-administration of GP and Akt inhibitors synergistically exerted anti-tumor activities on HeLa cells, suggesting the involvement of PI3-kinase/Akt. pathway in GP-induced cell death of the cancer cells. Indeed, the cytotoxic effect of GP against HeLa cells was inhibited by overexpression of constituvely active form of Akt in HeLa cells. The candidates of the functional proteins in GP were analyzed by Mass-spectrum. Taken together, our results suggest that GP elicits anti-tumor activity against HeLa cells by inhibition of PI3-kinase/Akt pathway. | - |
| dc.format.extent | 5 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY | - |
| dc.title | Gecko Proteins Exert Anti-Tumor Effect against Cervical Cancer Cells Via PI3-Kinase/Akt Pathway | - |
| dc.type | Article | - |
| dc.publisher.location | 대한민국 | - |
| dc.identifier.doi | 10.4196/kjpp.2012.16.5.361 | - |
| dc.identifier.scopusid | 2-s2.0-84869843310 | - |
| dc.identifier.wosid | 000311014800012 | - |
| dc.identifier.bibliographicCitation | KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, v.16, no.5, pp 361 - 365 | - |
| dc.citation.title | KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY | - |
| dc.citation.volume | 16 | - |
| dc.citation.number | 5 | - |
| dc.citation.startPage | 361 | - |
| dc.citation.endPage | 365 | - |
| dc.type.docType | Article | - |
| dc.identifier.kciid | ART001711972 | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.description.journalRegisteredClass | kci | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalResearchArea | Physiology | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Physiology | - |
| dc.subject.keywordPlus | HEPATOMA SMMC-7721 CELLS | - |
| dc.subject.keywordPlus | INHIBITOR | - |
| dc.subject.keywordPlus | MIGRATION | - |
| dc.subject.keywordPlus | COMPLEX | - |
| dc.subject.keywordAuthor | Cervical cancer | - |
| dc.subject.keywordAuthor | Gecko | - |
| dc.subject.keywordAuthor | Lizard | - |
| dc.subject.keywordAuthor | PI3-kinase | - |
| dc.subject.keywordAuthor | Tumor | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Gyeongsang National University Central Library, 501, Jinju-daero, Jinju-si, Gyeongsangnam-do, 52828, Republic of Korea+82-55-772-0532
COPYRIGHT 2022 GYEONGSANG NATIONAL UNIVERSITY LIBRARY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
